Tachycardia in pediatric patients can be a normal physiologic response (e.g., fever, dehydration) or a life-threatening arrhythmia (e.g., supraventricular tachycardia [SVT] or ventricular tachycardia [VT]). Early differentiation between stable and unstable tachycardia is critical for guiding treatment.
Key Goals of Tachycardia Management:
Differentiate between sinus tachycardia, SVT, and VT.
Determine if the patient is stable or unstable.
Provide appropriate treatment, including vagal maneuvers, medications, or cardioversion.
Tachycardia Type Rate Rhythm P Wave QRS Duration Key Features
Sinus Tachycardia <220 bpm (infants) <180 bpm (children) Regular Present Narrow Responds to fluids, rest, or fever control
Supraventricular Tachycardia (SVT) >220 bpm (infants), >180 bpm (children) Regular Absent or hidden Narrow Sudden onset, poor perfusion, no variability with movement
Ventricular Tachycardia (VT) Variable Regular Absent Wide (>0.09 sec) May have poor perfusion, risk of deterioration to VF/PEA
Key Differentiators:
Signs of Unstable Tachycardia (Shock Symptoms):
If unstable β Immediate synchronized cardioversion (Step 3).
If stable β Further rhythm assessment (Step 2).
Sinus Tachycardia:
Narrow Complex Tachycardia (SVT suspected, QRS <0.09 sec):
Wide Complex Tachycardia (VT suspected, QRS >0.09 sec):
Do NOT use adenosine for wide complex tachycardiaβit may worsen VT.
Indications for Synchronized Cardioversion:
Cardioversion Doses:
For awake children, consider sedation before cardioversion if time allows.
Narrow Complex Tachycardia (SVT):
Adenosine (first-line for SVT)
Wide Complex Tachycardia (VT):
Amiodarone: 5 mg/kg IV over 20-60 minutes (max 300 mg).
Procainamide (alternative to amiodarone): 15 mg/kg IV over 30-60 minutes.
Avoid using amiodarone and procainamide together due to risk of QT prolongation and arrhythmias.
Step | Action | Key Considerations |
---|---|---|
1 | Assess Stability | Unstable? β Immediate synchronized cardioversion |
2 | Identify Rhythm | Sinus tachycardia, SVT, or VT? |
3 | Vagal Maneuvers (if stable SVT) | Ice to face, Valsalva maneuver |
4 | Adenosine (if SVT persists) | 0.1 mg/kg IV push, repeat 0.2 mg/kg if needed |
5 | Cardioversion for Unstable Tachycardia | 0.5-1 J/kg β increase to 2 J/kg |
6 | Amiodarone/Procainamide for VT | 5 mg/kg IV over 20-60 min (Amiodarone) |
If SVT is refractory to adenosine:
If VT is refractory to medications or cardioversion:
If WPW Syndrome (Wolff-Parkinson-White) is suspected:
Heart rate normalizes for age.
Strong pulses, normal capillary refill (<2 sec).
Improved mental status (alert, responsive).
Stable blood pressure and perfusion.
If these signs are absent, continue resuscitation and escalate treatment.
Distinguish sinus tachycardia from life-threatening arrhythmias.
SVT responds well to vagal maneuvers and adenosine.
VT requires urgent managementβsynchronized cardioversion if unstable.
Identify and correct underlying causes (fever, dehydration, myocarditis, WPW).
Takeaway: Prompt recognition and intervention in pediatric tachycardia can prevent deterioration into cardiac arrest and improve outcomes.